Helen Devos Children's Hospital

Grand Rapids, Michigan 49546

16 studies enrolling now · 63 studies all time

What they study most

ATRT Recurrent, Acute Kidney Injury, Acute Kidney Injury in Pediatric Patients, Acute Lymphoblastic Leukemia (ALL), Acute Lymphoblastic Leukemia, Pediatric, Acute Myelogenous Leukemia (AML or ANLL), Acute Respiratory Distress Syndrome, Adult Congenital Heart Disease, Anti-myostatin, Atrophy, Autoimmune Diseases, Bone Marrow Failure Syndromes

Studies at this site

• Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT — Recruiting now
• Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children — Recruiting now
• Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study — Recruiting now
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
• Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes — Recruiting now
• Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders — Recruiting now
• Pediatric Precision Laboratory Advanced Neuroblastoma Therapy — Recruiting now
• Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy — Recruiting now
• Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma — Recruiting now
• Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation — Recruiting now
• Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors — Recruiting now
• Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry — Recruiting now
• Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus — Recruiting now
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry — Recruiting now
• Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children — Recruiting now
• Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System — Recruiting now
• A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) — Running, not enrolling
• AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) — Running, not enrolling
• ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) — Running, not enrolling
• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma — Running, not enrolling
• Neuroblastoma Maintenance Therapy Trial — Running, not enrolling
• HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors — Running, not enrolling
• PV Loop & Coarctation Study — Running, not enrolling
• Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes — Completed
• Copper Histidinate Treatment for Menkes Disease — APPROVED_FOR_MARKETING
• Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2 — Completed
• Vaccine Immune Recovery After Leukemia — Completed
• Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam — Completed
• Molecular-Guided Therapy for Childhood Cancer — Completed
• Prospective Study of Pregnancy in Women With Cystic Fibrosis — Running, not enrolling
• CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes — Running, not enrolling
• Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children — Stopped early
• Evaluation of the Duration of Therapy for Thrombosis in Children — Completed
• Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab — Running, not enrolling
• Pediatric Obesity Weight Evaluation Registry (POWER) Study — Completed
• A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function — Completed
• Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy — Completed
• An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy — Completed
• Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study — Completed
• Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic Fibrosis — Completed
• Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide — Completed
• Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma — Completed
• Trial of Tolcapone With Oxaliplatin for Neuroblastoma — Stopped early
• Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma — Stopped early
• Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission — Completed
• Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma — Completed
• Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer — Completed
• Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma — Stopped early
• Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma — Stopped early
• Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma — Completed